Chemoinformaics analysis of Hop-21(22)-ene solution
| Molecular Weight | 410.73 | nRot | 0 |
| Heavy Atom Molecular Weight | 360.33 | nRig | 26 |
| Exact Molecular Weight | 410.391 | nRing | 5 |
| Solubility: LogS | -7.458 | nHRing | 0 |
| Solubility: LogP | 8.006 | No. of Aliphatic Rings | 5 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 5 |
| Atoms Count | 80 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 30 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 5 |
| No. of Hydrogen atom | 50 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 30 | No. of Saturated Rings | 5 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 83.4397 |
| nHD | 0 | BPOL | 50.1604 |
| QED | 0.349 |
| Synth | 4.57 |
| Natural Product Likeliness | 2.352 |
| NR-PPAR-gamma | 0.022 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.012 |
| Pgp-sub | 0 |
| HIA | 0.007 |
| CACO-2 | -5.084 |
| MDCK | 0.00000732 |
| BBB | 0.019 |
| PPB | 0.93708 |
| VDSS | 2.961 |
| FU | 0.0179158 |
| CYP1A2-inh | 0.035 |
| CYP1A2-sub | 0.419 |
| CYP2c19-inh | 0.085 |
| CYP2c19-sub | 0.965 |
| CYP2c9-inh | 0.085 |
| CYP2c9-sub | 0.651 |
| CYP2d6-inh | 0.065 |
| CYP2d6-sub | 0.788 |
| CYP3a4-inh | 0.236 |
| CYP3a4-sub | 0.373 |
| CL | 4.607 |
| T12 | 0.036 |
| hERG | 0.094 |
| Ames | 0.001 |
| ROA | 0.075 |
| SkinSen | 0.675 |
| Carcinogencity | 0.012 |
| EI | 0.902 |
| Respiratory | 0.373 |
| NR-Aromatase | 0.025 |
| Antiviral | No |
| Prediction | 0.660235 |